Single Dose Safety, Tolerance and Pharmacokinetic Study in Healthy Volunteers Undergoing Contrast-enhanced Abdominal Computed Tomography (CT)

NCT01004770 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: GE-145 (AN113111) Injection
DRUG: Visipaque (iodixanol) Injection

Sponsor

GE Healthcare

Collaborators

[object Object]
[object Object]